News
March 15, 2018
Engineers Sweep Entrepreneur Challenge Startup Stage at Ignite
Engineers showed up in force at the second annual Ignite Conference pitch competition at UC San Diego. Almost a third of the 29 startups pitching their innovative business ideas during the Entrepreneur Challenge-led elevator pitch competition were founded by engineers—including the first, second and third place winners. That’s right, it was an engineering clean sweep. Full Story
March 12, 2018
Engineers develop most efficient red-light-activated switch that can turn genes on and off in mammalian cells
A team of researchers has developed a light-activated switch that can turn genes on and off in mammalian cells. This is the most efficient so-called “optogenetic switch” activated by red and far-red light that has been successfully designed and tested in animal cells—and it doesn’t require the addition of light sensing molecules from outside the cells. Full Story
March 5, 2018
How a Yeast Cell Helps Crack Open the 'Black Box' Behind Artificial Intelligence
A research team recently developed what they call a “visible” neural network and used it to build DCell, a model of a functioning brewer’s yeast cell, commonly used as a model in basic research. To do this, they amassed all knowledge of cell biology in one place and created a hierarchy of these cellular components. Then they mapped standard machine learning algorithms to this knowledgebase. Full Story
February 27, 2018
New online tool gives 3D view of human metabolic processes
A new computational resource called Recon3D provides a 3D view of genes, proteins and metabolites involved in human metabolism. Researchers used the tool to map disease-related mutations on proteins and also probed how genes and proteins change in response to certain drugs. The work provides a better understanding of disease-causing mutations and could enable researchers to discover new uses for existing drug treatments. Full Story
February 22, 2018
How Bacteria Steal Antibiotic-Resistant Genes
Researchers at the University of California San Diego Center for Microbiome Innovation have identified the mechanism by which a clinically relevant bacterium may gain antibiotic resistance, and have come up with a model for predicting the conditions under which it spreads. The findings, which establish a framework for understanding, quantifying and hopefully combating the emergence of superbugs, were published in a recent paper in eLife. Full Story
February 16, 2018
UC San Diego Bioengineering Student Wins Winston Churchill Scholarship
Aswini Krishnan, a fourth-year bioengineering major at the University of California San Diego, has been awarded a Winston Churchill Scholarship, one of the most prestigious and competitive awards available to American students pursuing science, mathematics and engineering fields. The award provides one year of funding to pursue a master’s degree at Winston Churchill College at the University of Cambridge. Krishnan is the fourth UC San Diego student to receive the award since the program’s inception in 1963. Full Story
January 15, 2018
Researchers develop a remote-controlled cancer immunotherapy system
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells. Full Story
January 11, 2018
From Class to Clinic
It’s not every day that an undergraduate class influences the way surgeons prepare for operations. But that’s exactly what happened with a freshman bioengineering class co-taught by then-PhD student Jason Caffrey ’11, MS ’13‚ and professor Robert Sah. Full Story
December 11, 2017
Updated brain cell map connects various brain diseases to specific cell types
Researchers have developed new single-cell sequencing methods that could be used to map the cell origins of various brain disorders, including Alzheimer’s, Parkinson’s, schizophrenia and bipolar disorder. By analyzing individual nuclei of cells from adult human brains, researchers have identified 35 different subtypes of neurons and glial cells and discovered which of these subtypes are most susceptible to common risk factors for different brain diseases. Full Story
December 5, 2017
Experimental drug blocks toxic ion flow linked to Alzheimer's disease
A new small-molecule drug can restore brain function and memory in a mouse model of Alzheimer’s disease. The molecule, called anle138b, works by stopping toxic ion flow in the brain that is known to trigger nerve cell death. Scientists envision that this drug could be used to treat Alzheimer’s and other neurodegenerative diseases such as Parkinson’s and ALS. Full Story